Biocompatibility and launch profiles of the nanovehicle in vitro. (A) Cell viabilities of BMSCs treated by FSR NPs at many different concentrations for 24h and 72h. 0. These benefits provided compelling evidence that the as-geared up FSR nanoparticles possessed exceptional catalytic Homes for chemodynamic therapy in the tumor microenvironment, where https://waltn776yju2.salesmanwiki.com/user